MARKET

BIIB

BIIB

Biogen Inc
NASDAQ
188.99
-4.82
-2.49%
Closed 19:47 02/10 EST
OPEN
194.07
PREV CLOSE
193.81
HIGH
195.72
LOW
188.74
VOLUME
1.84M
TURNOVER
176.53M
52 WEEK HIGH
202.41
52 WEEK LOW
110.04
MARKET CAP
27.73B
P/E (TTM)
21.50
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Biogen (BIIB) and Quest Diagnostics (DGX)
TipRanks · 6h ago
Top Biotech Executive Makes Significant Insider Move at Biogen
TipRanks · 8h ago
Biogen Is Maintained at Neutral by Wedbush
Dow Jones · 19h ago
Biogen Price Target Raised to $187.00/Share From $178.00 by Wedbush
Dow Jones · 19h ago
Wedbush Maintains Neutral on Biogen, Raises Price Target to $187
Benzinga · 19h ago
Biogen price target raised to $187 from $178 at Wedbush
TipRanks · 20h ago
BIOGEN <BIIB.O>: WEDBUSH RAISES TARGET PRICE TO $187 FROM $178
Reuters · 22h ago
Biogen Refocuses On High-Need Neurology As New Drugs Reach Inflection Point
Simply Wall St · 1d ago
More
About BIIB
Biogen Inc. is a global biopharmaceutical company. The Company is focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It operates a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS, and FUMADERM for the treatment of severe plaque psoriasis. It also collaborations with Eisai on the commercialization of LEQEMBI for the treatment of Alzheimer's disease and Sage on the commercialization of ZURZUVAE for the treatment of Postpartum Depression (PPD).

Webull offers Biogen Inc stock information, including NASDAQ: BIIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIIB stock methods without spending real money on the virtual paper trading platform.